Live Updates COVID-19 CASES
-
World
-
Egypt
investment company that owns specialized healthcare projects in the MENA region Paradise pharma is a leading healthcare investment company that owns specialized healthcare projects in the MENA region, constantly involved in providing healthcare solutions that address the needs of Healthcare Professionals, Patients and Societies – products to treat diseases, enhance the quality of life and consider the lifestyle. Using global sources we will continue to achieve our main goal Improve health and well-being at every stage of life”. Being recognized by all our stakeholders as a leading total Healthcare company , though providing the highest quality medicines and lifestyle products and services for patients’ wellbeing. Keep providing healthcare professionals and consumer with the best price value products and services that address the needs of patients and societies products to treat diseases, enhance the quality of life and consider lifestyle. Strategic partnering is a key accelerator to achieve our strategy The challenge we face as business and as an industry are significant , Our business strategy positions us well to manage the challenges and leverage the opportunities to make a meaningful and sustained contribution to healthcare. A novel coronavirus is a new coronavirus that has not been previously identified. The virus causing coronavirus disease 2019 (COVID-19), is not the same as the coronaviruses that commonly circulate among humans and cause mild illness, like the common cold. A diagnosis with coronavirus 229E, NL63, OC43, or HKU1 is not the same as a COVID-19 diagnosis. Patients with COVID-19 will be evaluated and cared for differently than patients with common coronavirus diagnosis. On February 11, 2020 the World Health Organization announced an official name for the disease that is causing the 2019 novel coronavirus outbreak, first identified in Wuhan China. The new name of this disease is coronavirus disease 2019, abbreviated as COVID-19. In COVID-19, ‘CO’ stands for ‘corona,’ ‘VI’ for ‘virus,’ and ‘D’ for disease. Formerly, this disease was referred to as “2019 novel coronavirus” or “2019-nCoV”. There are many types of human coronaviruses including some that commonly cause mild upper-respiratory tract illnesses. COVID-19 is a new disease, caused be a novel (or new) coronavirus that has not previously been seen in humans. The name of this disease was selected following the World Health Organization (WHO) best practiceexternal iconexternal icon for naming of new human infectious diseases. People in the U.S. may be worried or anxious about friends and relatives who are living in or visiting areas where COVID-19 is spreading. Some people are worried about getting the disease from these people. Fear and anxiety can lead to social stigma, for example, toward people who live in certain parts of the world, people who have traveled internationally, people who were in quarantine, or healthcare professionals. Stigma is discrimination against an identifiable group of people, a place, or a nation. Stigma is associated with a lack of knowledge about how COVID-19 spreads, a need to blame someone, fears about disease and death, and gossip that spreads rumors and myths. Stigma hurts everyone by creating more fear or anger toward ordinary people instead of focusing on the disease that is causing the problem. People can fight stigma by providing social support in situations where you notice this is occurring. Stigma affects the emotional or mental health of stigmatized groups and the communities they live in. Stopping stigma is important to making communities and community members resilient. See resources on mental health and coping during COVID-19. Everyone can help stop stigma related to COVID-19 by knowing the facts and sharing them with others in your community.
Paradise Pharma
Paradise pharma is a leading healthcare
Paradise Pharma
For Health. For Life.
Paradise Pharma Vision
Paradise Pharma Mission
Paradise Pharma Values
Our Production
Nutraceutical products
Natural products
Unique systems
Beauty items
Our Strategic Priorities
Corona virus Disease Basics (COVID-19)
